Joint Effects of Obesity and Vitamin D Insufficiency on Insulin Resistance and Type 2 Diabetes

Results from the NHANES 2001–2006

Diabetes Care June 29, 2012
Shaum M. Kabadi, MPH?, Brian K. Lee, PHD and Longjian Liu, MD, PHD, MSC Longjian Liu, ll85 at drexel.edu
Department of Epidemiology and Biostatistics, Drexel University School of Public Health, Philadelphia, Pennsylvania

OBJECTIVE The possible interaction of serum 25-hydroxyvitamin D [25(OH)D] and obesity in regard to type 2 diabetes and insulin resistance has not been well studied. To explore the effect modification of obesity on the association between 25(OH)D and insulin resistance/type 2 diabetes, data were examined from a nationally representative sample.

RESEARCH DESIGN AND METHODS The analytic sample for the type 2 diabetes analysis (n = 12,900) was limited to participants from the National Health and Nutrition Examination Survey (NHANES) 2001–2006 over 20 years of age. Participants >20 years of age assigned to the morning session and free of diabetes were limited to the insulin resistance analysis (n = 5,806). Multiplicative interaction was assessed through a cross-product interaction term in a multiple logistic regression model. The presence of additive interaction between insufficient 25(OH)D and obesity (indicated by BMI or waist circumference) was evaluated by calculation of the relative excess risk due to interaction (RERI) and attributable proportion due to interaction (AP).

RESULTS There was no multiplicative interaction of insufficient 25(OH)D and obesity on type 2 diabetes or insulin resistance.
Furthermore, none of the RERI or AP values were statistically significant in the diabetes analysis.

However, there was strong additive interaction between abdominal obesity and insufficient 25(OH)D (RERI 6.45 [95% CI 1.03–11.52]) in regard to insulin resistance.

In addition, 47% of the increased odds of insulin resistance can be explained by interaction between insufficient 25(OH)D and high BMI (AP 0.47 [95% CI 0.08–0.87]).

CONCLUSIONS Within a cross-sectional, nationally representative sample, abdominal obesity and insufficient 25(OH)D interact to synergistically influence the risk of insulin resistance.

Received February 2, 2012, Accepted April 29, 2012, © 2012 by the American Diabetes Association.
- - - - - - - - - - - - - - - - - - - -
Note: Not all obesity, just abdominal obesity

See also Vitamin D Life

• All items in category Diabetes and Vitamin D 454 items
• All items in category Obesity and Vitamin D 352 items
• Overview Diabetes and vitamin D
• Overview Obesity and Vitamin D
• Obesity lowers vitamin D which increases probability of diabetes in children – Nov 2011
• Low vitamin D associated with obesity-related diseases for ethnic minorities – Sept 2011
• Metabolic Syndrome and vitamin D Diabetes is one of the Metabolic Syndrome diseases